Abstract
Background Elevated plasma/serum troponin, indicating perioperative myocardial injury (PMI), is common after non-cardiac surgery. However, underlying mechanisms remain unclear. Acute coronary syndrome (ACS) is associated with the early appearance of circulating microRNAs, which regulate post-translational gene expression. We hypothesised that if PMI and ACS share pathophysiological mechanisms, common microRNA signatures should be evident.
Methods Nested case-control study of samples obtained before and after non-cardiac surgery from patients enrolled in two prospective observational studies of PMI (postoperative troponin I/T>99th centile). In cohort one, serum microRNAs were compared between patients with/without PMI, matched for age, gender and comorbidity. Real-time polymerase chain reaction quantified relative microRNA expression (cycle quantification threshold <37) before and after surgery for microRNA signatures associated with ACS, blinded to PMI. In cohort two, we analysed (EdgeR) microRNA from plasma extracellular vesicles using next-generation sequencing (Illumina HiSeq500). microRNA-messenger RNA-function pathway analysis was performed (DIANA miRPath v3.0/TopGO).
Results MicroRNA were detectable in all 59 patients (median age:67yrs (61-75); 42% male), who had similar clinical characteristics independent of developing PMI. In cohort one, PMI was not associated with increased serum microRNA expression levels after surgery (hsa-miR-1-3p mean fold-change (FC):3.99 (95%CI:1.95-8.19); hsa-miR-133-3p FC:5.67(95%CI:2.94-10.91); p<0.001). hsa-miR-208b-3p was more commonly detected after PMI (odd ratio (OR):10.0 (95%CI:1.9-52.6); p<0.01). Bioinformatic analysis of differentially expressed microRNAs from cohorts one and two identified pathways associated with adrenergic stress involving calcium dysregulation, rather than ischaemia.
Conclusions Circulating microRNAs synonymous with cardiac ischaemia were universally elevated in patients after surgery, independent of developing myocardial injury.
Competing Interest Statement
GLA is an Editor for Intensive Care Medicine Experimental and British Journal of Anaesthesia. GLA has undertaken consultancy work for GlaxoSmithKline; RMP has received research grants or honoraria from Edwards Lifesciences, Intersurgical, B. Braun, and GlaxoSmithKline. New Investigator Award from the Canadian Institutes of Health Research to DNW; Endowed Chair in Translational Anesthesiology Research at St Michael’s Hospital and University of Toronto to DNW; Merit Awards from the Department of Anesthesia at the University of Toronto to DNW, CDM, and BHC; Medical Research Council (UK) Clinical Research Training Fellowship to TEFA; TEFA is a member of the asso-ciate editorial board of British Journal of Anaesthesia; British Journal of Anaesthesia and Royal Col-lege of Anaesthetists Basic Science Career Development Award to GLA; British Oxygen Company Research Chair Grant in Anaesthesia from the Royal College of Anaesthetists to GLA; British Heart Foundation Programme Grant ( RG/14/4/30736 ) to GLA. The METS study was supported by grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Ontario Ministry of Health and Long-Term Care, Ontario Ministry of Research and Innovation, United Kingdom (UK) National Institute of Academic Anaesthesia, UK Clinical Research Collaboration, Australi-an and New Zealand College of Anaesthetists, and Monash University (Melbourne, Victoria, Australia).
Funding Statement
Declarations GLA is an Editor for Intensive Care Medicine Experimental and British Journal of Anaesthesia. GLA has undertaken consultancy work for GlaxoSmithKline; TEFA is a member of the associate editorial board of British Journal of Anaesthesia; there are no other relationships or activities that could appear to have influenced the submitted work. Sources of funding GLA is supported by British Journal of Anaesthesia/Royal College of Anaesthetists basic science Career Development award, British Oxygen Company research chair grant in anaesthesia from the Royal College of Anaesthetists and British Heart Foundation Programme Grant (RG/14/4/30736). New Investigator Award from the Canadian Institutes of Health Research to DNW; Endowed Chair in Translational Anesthesiology Research at St Michael’s Hospital and University of Toronto to DNW; Merit Awards from the Department of Anesthesia at the University of Toronto to DNW, CDM, and BHC; Medical Research Council (UK) Clinical Research Training Fellowship to TEFA. The METS study was supported by grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Ontario Ministry of Health and Long-Term Care, Ontario Ministry of Research and Innovation, United Kingdom (UK) National Institute of Academic Anaesthesia, UK Clinical Research Collaboration, Australian and New Zealand College of Anaesthetists, and Monash University (Melbourne, Victoria, Australia).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE144777.
